orphan and rare disease

Search documents
Catalyst Pharmaceuticals (CPRX) 2025 Conference Transcript
2025-09-04 20:22
Catalyst Pharmaceuticals (CPRX) 2025 Conference September 04, 2025 03:20 PM ET Company ParticipantsRichard Daly - President, CEO & DirectorJennifer Kim - Equity Research Director, BioPharma & BiotechSteven Miller - Executive VP, COO & Chief Scientific OfficerRichard DalyReady? Whenever you are.Jennifer KimAll right. Hi, everyone. Welcome to our fireside chat with Catalyst Pharmaceuticals. My name is Jennifer Kim. I'm one of the Research Analysts here at Cantor. I'm excited to welcome Richard J. Daly, CEO, a ...